Skip to main content
Top
Published in: Archives of Dermatological Research 8/2023

19-05-2023 | Bullous Pemphigoid | ORIGINAL PAPER

Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are positively correlated with disease activity of bullous pemphigoid

Authors: Chao Sun, Xiaoguang Li, Hua Qian, Guirong Liang, Ruiyu Xiang, Chenjing Zhao, Zhiliang Li, Suo Li, Ke Jing, Yuan Wang, Hanmei Zhang, Suying Feng

Published in: Archives of Dermatological Research | Issue 8/2023

Login to get access

Abstract

Bullous pemphigoid (BP) is a complex inflammatory process with elevated levels of autoantibodies, eosinophils, neutrophils, and various cytokines. Hematological inflammatory biomarkers can reflect inflammatory state in various diseases. Up to now, the correlations of hematological inflammatory biomarkers and disease activity of BP remain unknown. The purpose of this study was to clarify the associations between hematological inflammatory biomarkers and disease activity of BP. The levels of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), platelet-to-neutrophil ratio (PNR) and mean platelet volume (MPV) of 36 untreated BP patients and 45 age and gender matched healthy controls were detected by routine blood tests. The correlations between hematological inflammatory markers and clinical characteristics of BP were statistically analyzed. The Bullous Pemphigoid Disease Area Index (BPDAI) was used to measure disease activity of BP. The mean levels of NLR, PLR, PNR and MPV in 36 untreated BP patients were 3.9, 157.9, 45.7 and 9.4 fl, respectively. Increased NLR (p < 0.001), PLR (p < 0.01), and MPV (p < 0.001) but decreased PNR (p < 0.001) were observed in BP patients when compared with healthy controls. In BP patients, the levels of NLR were positively correlated to BPDAI Erosion/Blister Scores (p < 0.01); and the levels of NLR and PLR were both positively correlated to BPDAI without Damage Score (both p < 0.05) and BPDAI Total Score (both p < 0.05). No correlation was found in other statistical analyses between hematological inflammatory markers and clinical characteristics in BP patients involved in the present study. Therefore, NLR and PLR are positively correlated with disease activity of BP.
Appendix
Available only for authorised users
Literature
1.
go back to reference Nishie W (2014) Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII. J Dermatol Sci 73(3):179–186PubMedCrossRef Nishie W (2014) Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII. J Dermatol Sci 73(3):179–186PubMedCrossRef
2.
go back to reference Kasperkiewicz M, Zillikens D (2007) The pathophysiology of bullous pemphigoid. Clin Rev Allergy Immunol 33(1–2):67–77PubMedCrossRef Kasperkiewicz M, Zillikens D (2007) The pathophysiology of bullous pemphigoid. Clin Rev Allergy Immunol 33(1–2):67–77PubMedCrossRef
3.
go back to reference Goletz S, Zillikens D, Schmidt E (2017) Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases. Exp Dermatol 26(12):1154–1162PubMedCrossRef Goletz S, Zillikens D, Schmidt E (2017) Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases. Exp Dermatol 26(12):1154–1162PubMedCrossRef
4.
go back to reference Dopp R, Schmidt E, Chimanovitch I, Leverkus M, Brocker EB, Zillikens D (2000) IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity. J Am Acad Dermatol 42(4):577–583PubMed Dopp R, Schmidt E, Chimanovitch I, Leverkus M, Brocker EB, Zillikens D (2000) IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity. J Am Acad Dermatol 42(4):577–583PubMed
5.
go back to reference Daneshpazhooh M, Ghiasi M, Lajevardi V, Nasiri N, Balighi K, Teimourpour A et al (2018) BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid. Arch Dermatol Res 310(3):255–259PubMedCrossRef Daneshpazhooh M, Ghiasi M, Lajevardi V, Nasiri N, Balighi K, Teimourpour A et al (2018) BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid. Arch Dermatol Res 310(3):255–259PubMedCrossRef
6.
go back to reference Ishiura N, Fujimoto M, Watanabe R, Nakashima H, Kuwano Y, Yazawa N et al (2008) Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid. J Dermatol Sci 49(2):153–161PubMedCrossRef Ishiura N, Fujimoto M, Watanabe R, Nakashima H, Kuwano Y, Yazawa N et al (2008) Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid. J Dermatol Sci 49(2):153–161PubMedCrossRef
7.
go back to reference Muhammed N, Korgaonkar S, Pradhan V, Khopkar US (2021) A Cross-sectional study to correlate disease severity in bullous pemphigoid patients with serum levels of autoantibodies against BP180 and BP230. Indian Dermatol Online J 12(5):696–700PubMedPubMedCentralCrossRef Muhammed N, Korgaonkar S, Pradhan V, Khopkar US (2021) A Cross-sectional study to correlate disease severity in bullous pemphigoid patients with serum levels of autoantibodies against BP180 and BP230. Indian Dermatol Online J 12(5):696–700PubMedPubMedCentralCrossRef
8.
go back to reference Lee EH, Kim YH, Kim S, Kim SE, Kim SC (2012) Usefulness of enzyme-linked immunosorbent assay using recombinant BP180 and BP230 for serodiagnosis and monitoring disease activity of bullous pemphigoid. Ann Dermatol 24(1):45–55PubMedPubMedCentralCrossRef Lee EH, Kim YH, Kim S, Kim SE, Kim SC (2012) Usefulness of enzyme-linked immunosorbent assay using recombinant BP180 and BP230 for serodiagnosis and monitoring disease activity of bullous pemphigoid. Ann Dermatol 24(1):45–55PubMedPubMedCentralCrossRef
9.
go back to reference Cai SC, Lim YL, Li W, Allen JC, Chua SH, Tan SH et al (2015) Anti-BP180 NC16A IgG titres as an indicator of disease activity and outcome in Asian patients with bullous pemphigoid. Ann Acad Med Singap 44(4):119–126PubMedCrossRef Cai SC, Lim YL, Li W, Allen JC, Chua SH, Tan SH et al (2015) Anti-BP180 NC16A IgG titres as an indicator of disease activity and outcome in Asian patients with bullous pemphigoid. Ann Acad Med Singap 44(4):119–126PubMedCrossRef
10.
go back to reference Tsuji-Abe Y, Akiyama M, Yamanaka Y, Kikuchi T, Sato-Matsumura KC, Shimizu H (2005) Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP180 ELISA kit in bullous pemphigoid. J Dermatol Sci 37(3):145–149PubMedCrossRef Tsuji-Abe Y, Akiyama M, Yamanaka Y, Kikuchi T, Sato-Matsumura KC, Shimizu H (2005) Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP180 ELISA kit in bullous pemphigoid. J Dermatol Sci 37(3):145–149PubMedCrossRef
11.
go back to reference Feng S, Wu Q, Jin P, Lin L, Zhou W, Sang H et al (2008) Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Int J Dermatol 47(3):225–228PubMedCrossRef Feng S, Wu Q, Jin P, Lin L, Zhou W, Sang H et al (2008) Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Int J Dermatol 47(3):225–228PubMedCrossRef
12.
go back to reference Patsatsi A, Kyriakou A, Pavlitou-Tsiontsi A, Giannakou A, Sotiriadis D (2012) Association of autoantibodies to BP180 with disease activity in Greek patients with bullous pemphigoid. Clin Dev Immunol 2012:854795PubMedPubMedCentralCrossRef Patsatsi A, Kyriakou A, Pavlitou-Tsiontsi A, Giannakou A, Sotiriadis D (2012) Association of autoantibodies to BP180 with disease activity in Greek patients with bullous pemphigoid. Clin Dev Immunol 2012:854795PubMedPubMedCentralCrossRef
13.
go back to reference Hashimoto T, Ohzono A, Teye K, Numata S, Hiroyasu S, Tsuruta D et al (2017) Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid. Br J Dermatol 177(1):141–151PubMedCrossRef Hashimoto T, Ohzono A, Teye K, Numata S, Hiroyasu S, Tsuruta D et al (2017) Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid. Br J Dermatol 177(1):141–151PubMedCrossRef
14.
go back to reference van Beek N, Luttmann N, Huebner F, Recke A, Karl I, Schulze FS et al (2017) Correlation of serum levels of IgE autoantibodies against BP180 with bullous pemphigoid disease activity. JAMA Dermatol 153(1):30–38PubMedCrossRef van Beek N, Luttmann N, Huebner F, Recke A, Karl I, Schulze FS et al (2017) Correlation of serum levels of IgE autoantibodies against BP180 with bullous pemphigoid disease activity. JAMA Dermatol 153(1):30–38PubMedCrossRef
15.
go back to reference Schmidt E, Obe K, Brocker EB, Zillikens D (2000) Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 136(2):174–178PubMedCrossRef Schmidt E, Obe K, Brocker EB, Zillikens D (2000) Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 136(2):174–178PubMedCrossRef
16.
go back to reference Amo Y, Ohkawa T, Tatsuta M, Hamada Y, Fujimura T, Katsuoka K et al (2001) Clinical significance of enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J Dermatol Sci 26(1):14–18PubMedCrossRef Amo Y, Ohkawa T, Tatsuta M, Hamada Y, Fujimura T, Katsuoka K et al (2001) Clinical significance of enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J Dermatol Sci 26(1):14–18PubMedCrossRef
17.
go back to reference Marzano AV, Tedeschi A, Fanoni D, Bonanni E, Venegoni L, Berti E et al (2009) Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications. Br J Dermatol 160(2):266–272PubMedCrossRef Marzano AV, Tedeschi A, Fanoni D, Bonanni E, Venegoni L, Berti E et al (2009) Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications. Br J Dermatol 160(2):266–272PubMedCrossRef
18.
go back to reference Fang H, Shao S, Xue K, Yuan X, Qiao P, Zhang J et al (2021) Neutrophil extracellular traps contribute to immune dysregulation in bullous pemphigoid via inducing B-cell differentiation and antibody production. FASEB J 35(7):e21746PubMedCrossRef Fang H, Shao S, Xue K, Yuan X, Qiao P, Zhang J et al (2021) Neutrophil extracellular traps contribute to immune dysregulation in bullous pemphigoid via inducing B-cell differentiation and antibody production. FASEB J 35(7):e21746PubMedCrossRef
19.
go back to reference Park SH, Lee SH, Kim JH, Kim SC (2018) Circulating eosinophil and neutrophil counts correlate with disease severity in bullous pemphigoid. Ann Dermatol 30(5):544–549PubMedPubMedCentralCrossRef Park SH, Lee SH, Kim JH, Kim SC (2018) Circulating eosinophil and neutrophil counts correlate with disease severity in bullous pemphigoid. Ann Dermatol 30(5):544–549PubMedPubMedCentralCrossRef
20.
go back to reference de Graauw E, Sitaru C, Horn M, Borradori L, Yousefi S, Simon HU et al (2017) Evidence for a role of eosinophils in blister formation in bullous pemphigoid. Allergy 72(7):1105–1113PubMedCrossRef de Graauw E, Sitaru C, Horn M, Borradori L, Yousefi S, Simon HU et al (2017) Evidence for a role of eosinophils in blister formation in bullous pemphigoid. Allergy 72(7):1105–1113PubMedCrossRef
21.
go back to reference Liu Z, Giudice GJ, Zhou X, Swartz SJ, Troy JL, Fairley JA et al (1997) A major role for neutrophils in experimental bullous pemphigoid. J Clin Investig 100(5):1256–1263PubMedPubMedCentralCrossRef Liu Z, Giudice GJ, Zhou X, Swartz SJ, Troy JL, Fairley JA et al (1997) A major role for neutrophils in experimental bullous pemphigoid. J Clin Investig 100(5):1256–1263PubMedPubMedCentralCrossRef
22.
go back to reference Liu Z, Shapiro SD, Zhou X, Twining SS, Senior RM, Giudice GJ et al (2000) A critical role for neutrophil elastase in experimental bullous pemphigoid. J Clin Investig 105(1):113–123PubMedPubMedCentralCrossRef Liu Z, Shapiro SD, Zhou X, Twining SS, Senior RM, Giudice GJ et al (2000) A critical role for neutrophil elastase in experimental bullous pemphigoid. J Clin Investig 105(1):113–123PubMedPubMedCentralCrossRef
23.
go back to reference Chiriac MT, Roesler J, Sindrilaru A, Scharffetter-Kochanek K, Zillikens D, Sitaru C (2007) NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage. J Pathol 212(1):56–65PubMedCrossRef Chiriac MT, Roesler J, Sindrilaru A, Scharffetter-Kochanek K, Zillikens D, Sitaru C (2007) NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage. J Pathol 212(1):56–65PubMedCrossRef
24.
go back to reference Liu Z, Sui W, Zhao M, Li Z, Li N, Thresher R et al (2008) Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model. J Autoimmun 31(4):331–338PubMedPubMedCentralCrossRef Liu Z, Sui W, Zhao M, Li Z, Li N, Thresher R et al (2008) Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model. J Autoimmun 31(4):331–338PubMedPubMedCentralCrossRef
25.
go back to reference Briand C, Gourier G, Poizeau F, Jelti L, Bachelerie M, Quereux G et al (2020) Characteristics of pruritus in bullous pemphigoid and impact on quality of life: a prospective cohort study. Acta Derm Venereol 100(18):adv00320PubMed Briand C, Gourier G, Poizeau F, Jelti L, Bachelerie M, Quereux G et al (2020) Characteristics of pruritus in bullous pemphigoid and impact on quality of life: a prospective cohort study. Acta Derm Venereol 100(18):adv00320PubMed
26.
go back to reference Lyakhovitsky A, Dascalu J, Drousiotis T, Barzilai A, Baum S (2021) Hematological inflammatory markers in patients with pemphigus vulgaris. Dermatology 237(6):912–920PubMedCrossRef Lyakhovitsky A, Dascalu J, Drousiotis T, Barzilai A, Baum S (2021) Hematological inflammatory markers in patients with pemphigus vulgaris. Dermatology 237(6):912–920PubMedCrossRef
27.
go back to reference Akturk S, Buyukavci R (2017) Evaluation of blood neutrophil-lymphocyte ratio and platelet distribution width as inflammatory markers in patients with fibromyalgia. Clin Rheumatol 36(8):1885–1889PubMedCrossRef Akturk S, Buyukavci R (2017) Evaluation of blood neutrophil-lymphocyte ratio and platelet distribution width as inflammatory markers in patients with fibromyalgia. Clin Rheumatol 36(8):1885–1889PubMedCrossRef
28.
go back to reference Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD (2019) The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med 39(4):345–357PubMedPubMedCentralCrossRef Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD (2019) The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med 39(4):345–357PubMedPubMedCentralCrossRef
29.
go back to reference Gasparyan AY, Ayvazyan L, Pretorius E, Kitas GD (2014) Platelets in rheumatic diseases: friend or foe? Curr Pharm Des 20(4):552–566PubMedCrossRef Gasparyan AY, Ayvazyan L, Pretorius E, Kitas GD (2014) Platelets in rheumatic diseases: friend or foe? Curr Pharm Des 20(4):552–566PubMedCrossRef
30.
go back to reference Kato A, Hamada T, Miyake T, Morizane S, Hirai Y, Yamasaki O et al (2018) Clinical and laboratory markers associated with relapse in cutaneous polyarteritis nodosa. JAMA Dermatol 154(8):922–926PubMedPubMedCentralCrossRef Kato A, Hamada T, Miyake T, Morizane S, Hirai Y, Yamasaki O et al (2018) Clinical and laboratory markers associated with relapse in cutaneous polyarteritis nodosa. JAMA Dermatol 154(8):922–926PubMedPubMedCentralCrossRef
31.
go back to reference Lee YH, Song GG (2018) Neutrophil-to-lymphocyte ratio, mean platelet volume and platelet-to-lymphocyte ratio in Behcet’s disease and their correlation with disease activity: a meta-analysis. Int J Rheum Dis 21(12):2180–2187PubMedCrossRef Lee YH, Song GG (2018) Neutrophil-to-lymphocyte ratio, mean platelet volume and platelet-to-lymphocyte ratio in Behcet’s disease and their correlation with disease activity: a meta-analysis. Int J Rheum Dis 21(12):2180–2187PubMedCrossRef
32.
go back to reference Jaszczura M, Gora A, Grzywna-Rozenek E, Barc-Czarnecka M, Machura E (2019) Analysis of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and mean platelet volume to platelet count ratio in children with acute stage of immunoglobulin A vasculitis and assessment of their suitability for predicting the course of the disease. Rheumatol Int 39(5):869–878PubMedCrossRef Jaszczura M, Gora A, Grzywna-Rozenek E, Barc-Czarnecka M, Machura E (2019) Analysis of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and mean platelet volume to platelet count ratio in children with acute stage of immunoglobulin A vasculitis and assessment of their suitability for predicting the course of the disease. Rheumatol Int 39(5):869–878PubMedCrossRef
33.
go back to reference Atas H, Cemil BC, Kurmus GI, Gonul M (2016) Assessment of systemic inflammation with neutrophil-lymphocyte ratio in lichen planus. Postepy Dermatol Alergol 33(3):188–192PubMedPubMedCentralCrossRef Atas H, Cemil BC, Kurmus GI, Gonul M (2016) Assessment of systemic inflammation with neutrophil-lymphocyte ratio in lichen planus. Postepy Dermatol Alergol 33(3):188–192PubMedPubMedCentralCrossRef
35.
go back to reference Polat M, Bugdayci G, Kaya H, Oguzman H (2017) Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in Turkish patients with chronic plaque psoriasis. Acta Dermatovenerol Alp Pannonica Adriat 26(4):97–100PubMed Polat M, Bugdayci G, Kaya H, Oguzman H (2017) Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in Turkish patients with chronic plaque psoriasis. Acta Dermatovenerol Alp Pannonica Adriat 26(4):97–100PubMed
36.
go back to reference Qin B, Ma N, Tang Q, Wei T, Yang M, Fu H et al (2016) Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol 26(3):372–376PubMedCrossRef Qin B, Ma N, Tang Q, Wei T, Yang M, Fu H et al (2016) Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol 26(3):372–376PubMedCrossRef
37.
go back to reference Murrell DF, Daniel BS, Joly P, Borradori L, Amagai M, Hashimoto T et al (2012) Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. J Am Acad Dermatol 66(3):479–485PubMedCrossRef Murrell DF, Daniel BS, Joly P, Borradori L, Amagai M, Hashimoto T et al (2012) Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. J Am Acad Dermatol 66(3):479–485PubMedCrossRef
38.
go back to reference Rifaioglu EN, Sen BB, Ekiz O, Dogramaci AC (2014) Mean platelet volume and eosinophilia relationship in patients with bullous pemphigoid. Platelets 25(4):264–267PubMedCrossRef Rifaioglu EN, Sen BB, Ekiz O, Dogramaci AC (2014) Mean platelet volume and eosinophilia relationship in patients with bullous pemphigoid. Platelets 25(4):264–267PubMedCrossRef
39.
go back to reference Ozer I, Balevi S, Ataseven A (2018) Can neutrophil/lymphocyte ratio be used as a marker in the diagnosis of bullous pemphigoid? Selcuk Med J 34(2):65–69 Ozer I, Balevi S, Ataseven A (2018) Can neutrophil/lymphocyte ratio be used as a marker in the diagnosis of bullous pemphigoid? Selcuk Med J 34(2):65–69
40.
go back to reference Sereflican B, Parlak AH (2019) Clinical, demographical features, accompanying diseases and neutrophil to lymphocyte ratioplatelet to lymphocyte ratio in patients with bullous pemphigoid. Cumhur Med J 41(1):88–93 Sereflican B, Parlak AH (2019) Clinical, demographical features, accompanying diseases and neutrophil to lymphocyte ratioplatelet to lymphocyte ratio in patients with bullous pemphigoid. Cumhur Med J 41(1):88–93
41.
go back to reference Baxter JD (1976) Glucocorticoid hormone action. Pharmacol Ther B 2(3):605–669PubMed Baxter JD (1976) Glucocorticoid hormone action. Pharmacol Ther B 2(3):605–669PubMed
42.
go back to reference Baxter JD, Rousseau GG (1979) Glucocorticoid hormone action: an overview. Monogr Endocrinol 12:1–24PubMedCrossRef Baxter JD, Rousseau GG (1979) Glucocorticoid hormone action: an overview. Monogr Endocrinol 12:1–24PubMedCrossRef
43.
go back to reference Daneshpazhooh M, Shahdi M, Aghaeepoor M, Hasiri G, Chams C (2004) A comparative study of antibody titers of blister fluid and serum in patients with subepidermal immunobullous diseases. Int J Dermatol 43(5):348–351PubMedCrossRef Daneshpazhooh M, Shahdi M, Aghaeepoor M, Hasiri G, Chams C (2004) A comparative study of antibody titers of blister fluid and serum in patients with subepidermal immunobullous diseases. Int J Dermatol 43(5):348–351PubMedCrossRef
44.
go back to reference Patsatsi A, Vyzantiadis TA, Devliotou-Panagiotidou D, Chrysomallis F, Sotiriadis D (2008) Detection of anti-BP180NC16a and anti-BP230 autoantibodies in blister fluid of patients with bullous pemphigoid: the first survey in Greece. Clin Exp Dermatol 33(2):183–185PubMedCrossRef Patsatsi A, Vyzantiadis TA, Devliotou-Panagiotidou D, Chrysomallis F, Sotiriadis D (2008) Detection of anti-BP180NC16a and anti-BP230 autoantibodies in blister fluid of patients with bullous pemphigoid: the first survey in Greece. Clin Exp Dermatol 33(2):183–185PubMedCrossRef
45.
go back to reference Sernicola A, Russo I, Saponeri A, Alaibac M (2019) Biochip detection of BP180 autoantibodies in blister fluid for the serodiagnosis of bullous pemphigoid: a pilot study. Medicine (Baltimore) 98(7):e14514PubMedCrossRef Sernicola A, Russo I, Saponeri A, Alaibac M (2019) Biochip detection of BP180 autoantibodies in blister fluid for the serodiagnosis of bullous pemphigoid: a pilot study. Medicine (Baltimore) 98(7):e14514PubMedCrossRef
46.
go back to reference de Graauw E, Sitaru C, Horn MP, Borradori L, Yousefi S, Simon D et al (2018) Monocytes enhance neutrophil-induced blister formation in an ex vivo model of bullous pemphigoid. Allergy 73(5):1119–1130PubMedCrossRef de Graauw E, Sitaru C, Horn MP, Borradori L, Yousefi S, Simon D et al (2018) Monocytes enhance neutrophil-induced blister formation in an ex vivo model of bullous pemphigoid. Allergy 73(5):1119–1130PubMedCrossRef
Metadata
Title
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are positively correlated with disease activity of bullous pemphigoid
Authors
Chao Sun
Xiaoguang Li
Hua Qian
Guirong Liang
Ruiyu Xiang
Chenjing Zhao
Zhiliang Li
Suo Li
Ke Jing
Yuan Wang
Hanmei Zhang
Suying Feng
Publication date
19-05-2023
Publisher
Springer Berlin Heidelberg
Published in
Archives of Dermatological Research / Issue 8/2023
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-023-02639-w

Other articles of this Issue 8/2023

Archives of Dermatological Research 8/2023 Go to the issue